News

Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the first quarter ended March 31, 2026. “Acadia delivered a solid first quarter of 2026 with total revenues of $268 million, driven […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes

SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2032 (the “Notes”) in an underwritten […]

News

QuidelOrtho Reports First Quarter 2026 Financial Results

? LEX Diagnostics Acquisition Expected to Accelerate Growth in Point-of-Care Molecular Diagnostics ? ? Key Product Launches in U.S. and International Markets Expected to Drive Future Growth ? ? Company Updates Full-Year 2026 Financial Guidance […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and L?kahi Therapeutics to Advance Apitox Program

MATAWAN, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced a comprehensive settlement with Inscobee Inc. and Apimeds Inc. (the “Inscobee Parties”), resolving all outstanding disputes arising from the APUS’ […]

News

Sanford Burnham Prebys Medical Discovery Institute receives $5 million from Qualcomm co-founder Andrew Viterbi to advance AI-powered research

LA JOLLA, Calif., May 5, 2026 /PRNewswire/ — Sanford Burnham Prebys Medical Discovery Institute today announced that Andrew Viterbi, a visionary communications pioneer and co-founder of Qualcomm Inc., has made a $5 million gift to […]

News

Epirium Bio Presenting New Preclinical Data on its 15-PGDH Inhibitor Program in Inflammatory Bowel Disease at Digestive Disease Week® 2026

SAN DIEGO–(BUSINESS WIRE)–Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral 15-PGDH inhibitor program in inflammatory bowel disease (IBD), including […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Senhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination

TAIPEI and SAN DIEGO, May 5, 2026 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company today announced the initiation of a global, multi-center clinical trial. The Company has also submitted an Investigational […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today announced that 36-month results from patients […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Biotheryx to Present Results from its Phase 1A Dose Escalation Study of BTX-9341 for the Treatment of HR+/HER2- Breast Cancer at the 2026 European Society for Medical Oncology Breast Cancer Annual Congress

SAN DIEGO, May 4, 2026 /PRNewswire/ — Biotheryx, Inc., a biopharmaceutical company focused on the discovery and development of first-in-class protein degraders for cancer and inflammatory diseases, today announced that data from its Phase 1A […]

News

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-‘2118, a Corticotropin-Releasing Factor Type 2 Receptor Agonist

NBIP-‘2118 targets a new, non-incretin mechanism for weight loss with lean mass preservation SAN DIEGO, May 4, 2026 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of a Phase 1 first-in-human clinical […]


ADVERTISEMENT — Advertise With Biotech Networks
News

ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026

Pivotal posters at ASBrS 2026 highlight body composition monitoring, BIS, and lymphedema surveillance in breast cancer care CARLSBAD, Calif., May 1, 2026 /PRNewswire/ — ImpediMed, a leader in medical technologies to clinically monitor and manage […]


ADVERTISEMENT — Advertise With Biotech Networks
News

RationAle Brewing™ Partners with the Andy Irons Foundation to Launch “Check In Before You Drop In” Campaign for Mental Health Awareness Month

The non-alcoholic craft beer brand deepens its focus on supporting mental health awareness with a founder-led partnership rooted in surf culture, legacy, and real community impact SAN DIEGO, April 30, 2026 /PRNewswire-PRWeb/ — RationAle Brewing™ […]